GR3029884T3 - Method of preparing a radioactive rhenium complex solution. - Google Patents

Method of preparing a radioactive rhenium complex solution.

Info

Publication number
GR3029884T3
GR3029884T3 GR990400973T GR990400973T GR3029884T3 GR 3029884 T3 GR3029884 T3 GR 3029884T3 GR 990400973 T GR990400973 T GR 990400973T GR 990400973 T GR990400973 T GR 990400973T GR 3029884 T3 GR3029884 T3 GR 3029884T3
Authority
GR
Greece
Prior art keywords
preparing
complex solution
rhenium complex
radioactive rhenium
combined
Prior art date
Application number
GR990400973T
Other languages
English (en)
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GR3029884T3 publication Critical patent/GR3029884T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
GR990400973T 1992-10-27 1999-04-05 Method of preparing a radioactive rhenium complex solution. GR3029884T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (1)

Publication Number Publication Date
GR3029884T3 true GR3029884T3 (en) 1999-07-30

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400973T GR3029884T3 (en) 1992-10-27 1999-04-05 Method of preparing a radioactive rhenium complex solution.

Country Status (23)

Country Link
EP (1) EP0594950B1 (el)
JP (1) JPH07300427A (el)
KR (1) KR100289224B1 (el)
AT (1) ATE176157T1 (el)
AU (1) AU669570B2 (el)
CA (1) CA2109159A1 (el)
CZ (1) CZ283587B6 (el)
DE (2) DE69323264D1 (el)
DK (1) DK0594950T3 (el)
ES (1) ES2126616T3 (el)
FI (1) FI934725A (el)
GR (1) GR3029884T3 (el)
HK (1) HK1009931A1 (el)
HU (1) HU215149B (el)
IL (1) IL107387A (el)
LV (1) LV12271B (el)
NO (1) NO308588B1 (el)
NZ (1) NZ250029A (el)
PL (1) PL174130B1 (el)
RU (1) RU2121365C1 (el)
SG (1) SG47725A1 (el)
TW (1) TW256774B (el)
UA (1) UA27754C2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
CA2222455C (en) * 1995-03-22 2013-05-28 Smithkline Beecham Biologicals S.A. A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9608612A (pt) * 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
EP1762246A1 (en) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Multivalent DTP-Polio vaccines
PT1296715E (pt) * 2000-06-29 2012-01-19 Smithkline Beecham Biolog Composição vacinal multivalente
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
ES2649048T3 (es) 2002-11-01 2018-01-09 Glaxosmithkline Biologicals S.A. Procedimiento de secado
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
KR101408113B1 (ko) 2005-06-27 2014-06-16 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
LV12271A (lv) 1999-05-20
HK1009931A1 (en) 1999-06-11
DE69323264T4 (de) 1999-10-14
CZ227293A3 (en) 1994-05-18
AU5029093A (en) 1994-05-12
FI934725A (fi) 1994-04-28
ATE176157T1 (de) 1999-02-15
RU2121365C1 (ru) 1998-11-10
NZ250029A (en) 1994-09-27
EP0594950B1 (en) 1999-01-27
HUT67239A (en) 1995-03-28
ES2126616T3 (es) 1999-04-01
KR940008698A (ko) 1994-05-16
AU669570B2 (en) 1996-06-13
UA27754C2 (uk) 2000-10-16
JPH07300427A (ja) 1995-11-14
NO933856D0 (no) 1993-10-26
PL174130B1 (pl) 1998-06-30
LV12271B (en) 1999-07-20
CA2109159A1 (en) 1994-04-28
IL107387A0 (en) 1994-01-25
HU9303028D0 (en) 1994-01-28
FI934725A0 (fi) 1993-10-26
NO308588B1 (no) 2000-10-02
CZ283587B6 (cs) 1998-05-13
SG47725A1 (en) 1998-04-17
HU215149B (hu) 2000-03-28
KR100289224B1 (ko) 2001-05-02
DE69323264D1 (de) 1999-03-11
TW256774B (el) 1995-09-11
DK0594950T3 (da) 1999-09-13
EP0594950A1 (en) 1994-05-04
IL107387A (en) 1997-04-15
NO933856L (no) 1994-04-28
DE69323264T2 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
FI104046B1 (fi) Menetelmä konjugoidun oligosakkaridin valmistamiseksi
NO179164C (no) Fremgangsmåte for fremstilling av et immunogenkonjugat
GR3035081T3 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
GR3029884T3 (en) Method of preparing a radioactive rhenium complex solution.
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
EP0338265A3 (en) Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
US6165468A (en) Antigenic carbohydrate linked to an immunogenic carrier
Beuvery et al. Meningococcal group C polysaccharide/tetanus toxoid conjugate as immunogen.
Audibert et al. Of antigens, adjuvants, and carriers in synthetic vaccines.
MÄKELÄ et al. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
SE8400934L (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner